Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension

Version 1 : Received: 13 May 2024 / Approved: 14 May 2024 / Online: 14 May 2024 (13:10:13 CEST)

How to cite: Tobal, R.; Potjewijd, J.; Doorn, D. P. C. V.; Empel, V. V.; Damoiseaux, J.; Paassen, P. V. High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension. Preprints 2024, 2024050959. https://doi.org/10.20944/preprints202405.0959.v1 Tobal, R.; Potjewijd, J.; Doorn, D. P. C. V.; Empel, V. V.; Damoiseaux, J.; Paassen, P. V. High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension. Preprints 2024, 2024050959. https://doi.org/10.20944/preprints202405.0959.v1

Abstract

Pulmonary hypertension (PH) is a serious condition linked to immune-system dysfunction. Myositis-specific/associated antibodies (MSA/MAA) play a role in idiopathic inflammatory myopathy (IIM) and interstitial lung disease (ILD), but their significance in PH remains unclear. We believe the presence of these antibodies, may be underestimated. This study analyzed adult PH patients without pre-existing IIM for MSA/MAA prevalence using a line-blot assay. We compared PH patients with and without ILD signs to a cohort clinically suspected of IIM/ILD (n=558). Our PH cohort (n=121) showed a significantly higher prevalence of overall weak positive MSA/MAAs and positive overlap syndrome-associated MAAs than the suspected IIM/ILD group (p

Keywords

Pulmonary Hypertension; Myositis specific antibodies; Myositis associated antibodies; Immunology; auto-antibodies

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.